Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials.
Authors
Ní Chróinín, DanielleAsplund, Kjell
Asberg, Signild
Callaly, Elizabeth
Cuadrado-Godia, Elisa
Díez-Tejedor, Exuperio
Di Napoli, Mario
Engelter, Stefan T
Furie, Karen L
Giannopoulos, Sotirios
Gotto, Antonio M
Hannon, Niamh
Jonsson, Fredrik
Kapral, Moira K
Martí-Fàbregas, Joan
Martínez-Sánchez, Patricia
Milionis, Haralampos J
Montaner, Joan
Muscari, Antonio
Pikija, Slaven
Probstfield, Jeffrey
Rost, Natalia S
Thrift, Amanda G
Vemmos, Konstantinos
Kelly, Peter J
Affiliation
From the Neurovascular Unit for Applied Translational Research and Therapeutics, Mater University Hospital/Dublin Academic Medical Centre, University College Dublin, Ireland.Issue Date
2013-01-03
Metadata
Show full item recordCitation
Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials. 2013: StrokeJournal
Stroke; a journal of cerebral circulationDOI
10.1161/STROKEAHA.112.668277PubMed ID
23287777Abstract
Background-Although experimental data suggest that statin therapy may improve neurological outcome after acute cerebral ischemia, the results from clinical studies are conflicting. We performed a systematic review and meta-analysis investigating the relationship between statin therapy and outcome after ischemic stroke. METHODS: The primary analysis investigated statin therapy at stroke onset (prestroke statin use) and good functional outcome (modified Rankin score 0 to 2) and death. Secondary analyses included the following: (1) acute poststroke statin therapy (≤72 hours after stroke), and (2) thrombolysis-treated patients. RESULTS: The primary analysis included 113 148 subjects (27 studies). Among observational studies, statin treatment at stroke onset was associated with good functional outcome at 90 days (pooled odds ratio [OR], 1.41; 95% confidence interval [CI], 1.29-1.56; P<0.001), but not 1 year (OR, 1.12; 95% CI, 0.9-1.4; P=0.31), and with reduced fatality at 90 days (pooled OR, 0.71; 95% CI, 0.62-0.82; P<0.001) and 1 year (OR, 0.80; 95% CI, 0.67-0.95; P=0.01). In the single randomized controlled trial reporting 90-day functional outcome, statin treatment was associated with good outcome (OR, 1.5; 95% CI, 1.0-2.24; P=0.05). No reduction in fatality was observed on meta-analysis of data from 3 randomized controlled trials (P=0.9). In studies of thrombolysis-treated patients, an association between statins and increased fatality at 90 days was observed (pooled OR, 1.25; 95% CI, 1.02-1.52; P=0.03, 3 studies, 4339 patients). However, this association was no longer present after adjusting for age and stroke severity in the largest study (adjusted OR, 1.14; 95% CI, 0.90-1.44; 4012 patients). CONCLUSIONS: In the largest meta-analysis to date, statin therapy at stroke onset was associated with improved outcome, a finding not observed in studies restricted to thrombolysis-treated patients. Randomized trials of statin therapy in acute ischemic stroke are needed.Item Type
ArticleLanguage
enISSN
1524-4628ae974a485f413a2113503eed53cd6c53
10.1161/STROKEAHA.112.668277
Scopus Count
Collections
Related articles
- Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study.
- Authors: Ní Chróinín D, Callaly EL, Duggan J, Merwick Á, Hannon N, Sheehan Ó, Marnane M, Horgan G, Williams EB, Harris D, Kyne L, McCormack PM, Moroney J, Grant T, Williams D, Daly L, Kelly PJ
- Issue date: 2011 Apr
- Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
- Authors: Tsivgoulis G, Kadlecová P, Kobayashi A, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Katsanos AH, Rudolf J, Krespi Y, Mikulik R
- Issue date: 2015 Sep
- Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient).
- Authors: Yoshimura S, Uchida K, Daimon T, Takashima R, Kimura K, Morimoto T, ASSORT Trial Investigator
- Issue date: 2017 Nov
- Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.
- Authors: Scheitz JF, Seiffge DJ, Tütüncü S, Gensicke H, Audebert HJ, Bonati LH, Fiebach JB, Tränka C, Lyrer PA, Endres M, Engelter ST, Nolte CH
- Issue date: 2014 Feb
- Letter by Cappellari et al regarding article, "statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and Randomized Trials".
- Authors: Cappellari M, Moretto G, Bovi P
- Issue date: 2013 Jun